Funding Opportunity PA-17-451 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages small research project grants (R03) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research.

Funding Opportunity PAR-17-453 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to solicit Research Center applications for the Point-of-Care Technologies Research Network (POCTRN). POCTRNs purpose is to drive the development and application of appropriate point of care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. The POCTRN Research Centers will create a national research network that works to build expertise in the development of integrated systems that address unmet clinical needs in point-of-care testing and treatment through the creation of multidisciplinary partnerships. This opportunity is open to existing POCTRN grantees as well as new applicants.

Funding Opportunity RFA-CA-17-029 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to establish an Academic-Industrial Partnership Program to develop new and/or validate existing technologies, methods, and assays for the capture and quantification of tumor associated cells, DNA, RNA, or exosomes in body fluids of patients with early stage disease or those at high risk; as well as distinguishing cancer from benign disease; or aggressive from indolent cancers. The precompetitive alliances with industry will harmonize and validate technologies, methods and assays associated with liquid biopsies.

Notice NOT-CA-17-077 from the NIH Guide for Grants and Contracts

Notice NOT-OH-17-011 from the NIH Guide for Grants and Contracts

Notice NOT-HD-17-020 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-098 from the NIH Guide for Grants and Contracts

Notice NOT-HD-17-016 from the NIH Guide for Grants and Contracts

Notice NOT-HL-17-530 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NR-17-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications to establish NINR P20 Exploratory Centers. The P20 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The P20 may lead to Center sustainability and/or the ability to be funded through other specialized or comprehensive grants.

Funding Opportunity RFA-NR-17-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications to establish NINR P30 Center of Excellence. The P30 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The P30 may lead to Center sustainability and/or the ability to be funded through other specialized or comprehensive grants. The purpose of this program is to support NINR P30 Centers of Excellence to enhance interdisciplinary, biobehavioral research for scientists conducting research in multiple complex chronic conditions in human adult populations. This FOA is specifically designed with the intent to support the NINR Common Data Element (CDE) initiative.

Funding Opportunity PA-17-443 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support investigator-initiated R01 applications that will inform our understanding of the typical and atypical patterns of language and literacy development of dual language learners (DLLs) in the United States. Applicants are encouraged to take advantage of advances in the language sciences and related fields to identify and clarify specific cognitive, linguistic, neurobiological, and sociocultural factors associated with normal and impaired language and literacy acquisition in young DLL populations.

Funding Opportunity PA-17-448 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support investigator-initiated R21 applications that will inform our understanding of the typical and atypical patterns of language and literacy development of dual language learners (DLLs) in the United States. Applicants are encouraged to take advantage of advances in the language sciences and related fields to identify and clarify specific cognitive, linguistic, neurobiological, and sociocultural factors associated with normal and impaired language and literacy acquisition in young DLL populations.

Notice NOT-DA-17-050 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-17-447 from the NIH Guide for Grants and Contracts. The reproducibility and comparability of dietary supplement research is enhanced through rigorous analytical characterization of key experimental materials. The publication of analytical methods which have been thoroughly validated for specific, precise, accurate, and sensitive quantitative determination of chemical constituents of dietary supplements therefore makes critical contributions to the rigor and reproducibility of biomedical research. This FOA will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods. The methods proposed for validation must be used to identify and quantify chemical constituents (active or marker chemical compounds, adulterants, contaminants) or metabolites thereof in experimental reagents, raw materials, and/or clinical specimens (for example urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grants specific aims. Candidate constituents for quantitative method validation studies may include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA.

Funding Opportunity RFA-HL-18-024 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research on cardiovascular and pulmonary physiologic and health effects of electronic cigarette (e-cigarette) exposure. This FOA invites applications addressing the effects of e-cigarettes on the cardiovascular and pulmonary systems, alone or in combination. Studies involving clinical populations, animal models and/or cell preparations would all be considered responsive. Research may examine the effects of the whole e-cigarette aerosol or of individual components or constituents. Research may also examine where aerosols, components, or constituents deposit in the airways and resulting heart and/or lung consequences.

Notice NOT-CA-17-075 from the NIH Guide for Grants and Contracts

Notice NOT-CA-17-076 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-17-444 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Funding Opportunity PA-17-445 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.